Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colistin in Neonatal ICU Patients With Gram Negative Resistant Infection: Dosage Personalization Approach

NCT06472271 is registered in ClinicalTrials.gov with Mahmoud I Mostafa as lead sponsor.

NCT NCT06472271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colistin in Neonatal ICU Patients With Gram Negative Resistant Infection: Dosage Personalization Approach
Lead sponsor
Mahmoud I Mostafa
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2024
Completion date
October 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colistin adverse reaction